Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.
A biopharmaceutical may be a pharmaceutical drug product factory-made in, extracted from, or semi synthesized from biological sources. Completely different from synthesized prescription drugs, they embrace vaccines, blood, blood parts, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells employed in cell therapy. Biologics will be composed of sugars, proteins, or nucleic acids or advanced mixtures of those substances, or is also living cells or tissues. They are isolated from living sources human, animal, plant, fungal, or microorganism. They are proteins, nucleic acids used for therapeutic or in vivo diagnostic functions, and created by means that aside from direct extraction from a native biological supply. The primary substance approved for therapeutic use was recombinant human hypoglycemic agent. The massive majority of biopharmaceutical merchandise is prescription drugs that are derived from life forms. A doubtless polemic methodology of manufacturing biopharmaceuticals involves transgenic organisms, notably plants and animals that are genetically changed to supply medication. Gene-based and cellular biologics, for instance, typically are at the forefront of medical specialty analysis, and should be wont to treat a range of medical conditions that no alternative treatments are obtainable.
Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Biopharmaceutical drug, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.
Related article links for Biopharmaceutical drug will appear here as matching content is published in Pharmacovigilance and Pharmacoepidemiology (ISSN: 2638-8235). Readers can also browse the journal archive and current issue for connected research.
